Madsen L, Frøyland L, Grav H J, Berge R K
Department of Clinical Biology, University of Bergen, Haukeland Hospital, Norway.
J Lipid Res. 1997 Mar;38(3):554-63.
In the liver of rats, monocarboxylic 3-thia fatty acids, tridecylthioacetic acid (C13-S-acetic acid) and tetradecylthioacetic acid (C14-S-acetic acid), increase the mRNA levels of delta 9-desaturase both in a time- and dose-dependent manner. The increased delta 9-desaturase mRNA levels were accompanied by increased delta 9-desaturase activity and increased amounts of oleic acid (18:1 n-9) and delta 9-desaturated C14-S-acetic acid. delta 9-Desaturated C14-S-acetic acid was only detected in phospholipid and cholesterolester species after C14-S-acetic acid treatment. In contrast, C14-S-acetic acid was detected in all the different hepatic lipid fractions, but mainly in the phospholipids. Moreover, C13-S-acetic acid and C14-S-acetic acid were detected in both liver and very low density lipoprotein (VLDL). No delta 9-desaturated 3-thia fatty acid products, however, were found in VLDL. Administration of mono- and dicarboxylic 3-thia fatty acids to rats induced liver expression of the fatty acyl-CoA oxidase gene. After 1 week of C14-S-acetic acid treatment, the levels of fatty acyl-CoA oxidase mRNA increased 5-fold, whereas the delta 9-desaturase mRNA was increased about 1.8-fold. Both fatty acyl-CoA oxidase and delta 9-desaturase mRNA increased about 8-fold after 12 weeks of treatment with C14-S-acetic acid. In conclusion, this study demonstrates that C14-S-acetic acid increases rat delta 9-desaturase gene expression and activity and that changes in hepatic lipids, e.g., 18:1 n-9, are reflected in the VLDL. The peroxisome-proliferating monocarboxylic thia fatty acids are good substrates for desaturases, as delta 9-desaturated metabolites of monocarboxylated thia acids were formed in the liver. Modification of delta 9-desaturation, however, appears not to be related to peroxisome proliferation.
在大鼠肝脏中,单羧酸3-硫代脂肪酸、十三烷基硫代乙酸(C13-S-乙酸)和十四烷基硫代乙酸(C14-S-乙酸),均以时间和剂量依赖性方式增加Δ9-去饱和酶的mRNA水平。Δ9-去饱和酶mRNA水平的增加伴随着Δ9-去饱和酶活性的增加以及油酸(18:1 n-9)和Δ9-去饱和C14-S-乙酸含量的增加。仅在C14-S-乙酸处理后的磷脂和胆固醇酯种类中检测到Δ9-去饱和C14-S-乙酸。相比之下,在所有不同的肝脏脂质组分中均检测到C14-S-乙酸,但主要存在于磷脂中。此外,在肝脏和极低密度脂蛋白(VLDL)中均检测到C13-S-乙酸和C14-S-乙酸。然而,在VLDL中未发现Δ9-去饱和的3-硫代脂肪酸产物。给大鼠施用单羧酸和二羧酸3-硫代脂肪酸可诱导肝脏中脂肪酸酰基辅酶A氧化酶基因的表达。C14-S-乙酸处理1周后,脂肪酸酰基辅酶A氧化酶mRNA水平增加了5倍,而Δ9-去饱和酶mRNA增加了约1.8倍。用C14-S-乙酸处理12周后,脂肪酸酰基辅酶A氧化酶和Δ9-去饱和酶mRNA均增加了约8倍。总之,本研究表明C14-S-乙酸增加大鼠Δ9-去饱和酶基因表达和活性,并且肝脏脂质的变化,例如18:1 n-9,反映在VLDL中。过氧化物酶体增殖性单羧酸硫代脂肪酸是去饱和酶的良好底物,因为在肝脏中形成了单羧化硫代酸的Δ9-去饱和代谢产物。然而,Δ9-去饱和的修饰似乎与过氧化物酶体增殖无关。